The Long-Term Effects of Prenatal Nicotine Exposure on Neurologic Development

Journal of Midwifery and Women's Health

Volumn 55, Issue 2, 2010, Pages 143-152

  Blood Siegfried, Jane ^a   Rende, Elizabeth K ^a  

^a NONE

Author keywords

attention deficit hyperactivity disorder; fetal development; nicotine; pregnancy; smoking; sudden infant death syndrome

Indexed keywords

ACETYLCHOLINE; ADRENALIN; AMFEBUTAMONE; CATECHOLAMINE DERIVATIVE; DOPAMINE; NEUROTRANSMITTER; NICOTINE; NORADRENALIN; SEROTONIN; VARENICLINE;

ADOLESCENT SMOKING; ARTICLE; ATTENTION DEFICIT DISORDER; ATTENTION DISTURBANCE; AUTONOMIC NERVOUS SYSTEM; BEHAVIOR DISORDER; BRAIN CORTEX; CEREBELLUM; CLINICAL TRIAL; COGNITIVE THERAPY; CONGENITAL MALFORMATION; DEPRESSION; DRUG WITHDRAWAL; FETUS DEATH; FETUS DEVELOPMENT; HIPPOCAMPUS; HUMAN; HYPNOSIS; LACTATION; LEARNING DISORDER; LOW BIRTH WEIGHT; MATERNAL SMOKING; NERVOUS SYSTEM DEVELOPMENT; NEUROTRANSMISSION; NICOTINE REPLACEMENT THERAPY; NONHUMAN; PLACENTA PREVIA; PREECLAMPSIA; PREGNANCY; PREMATURITY; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROTEIN FUNCTION; SIDE EFFECT; SMOKING CESSATION; SMOKING CESSATION PROGRAM; SOLUTIO PLACENTAE; SUDDEN INFANT DEATH SYNDROME; TOBACCO DEPENDENCE;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BRAIN; CHILD; CHILD BEHAVIOR; FEMALE; FETAL DEVELOPMENT; GANGLIONIC STIMULANTS; HUMANS; INFANT, NEWBORN; MALE; NERVOUS SYSTEM; NERVOUS SYSTEM PHYSIOLOGICAL PHENOMENA; NICOTINE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RISK FACTORS; SMOKING; SMOKING CESSATION; SUDDEN INFANT DEATH; TIME FACTORS;

EID: 77249148940     PISSN: 15269523     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmwh.2009.05.006     Document Type: Article

References (81)

1. Castles A., Adams E.K., Melvin C.L., Kelsch C., and Boulton M.L. Effects of smoking during pregnancy. Five meta-analyses. Am J Prev Med 16 (1999) 208-215
2. Linnet K.M., Dalsgaard S., Obel C., Wisborg K., Henriksen T.B., Rodriguez A., et al. Maternal lifestyle factors in pregnancy risk of attention deficit hyperactivity disorder and associated behaviors: Review of the current evidence. Am J Psychiatry 160 (2003) 1028-1040
3. DiFranza J.R., Aligne C.A., and Weitzman M. Prenatal and postnatal environmental tobacco smoke exposure and children's health. Pediatrics 113 (2004) 1007-1015
4. Rose J.E. Nicotine and nonnicotine factors in cigarette addiction. Psychopharmacology (Berl) 184 (2006) 274-285
5. Lambers D.S., and Clark K.E. The maternal and fetal physiologic effects of nicotine. Semin Perinatol 20 (1996) 115-126
6. Anderson M.E., Johnson D.C., and Batal H.A. Sudden infant death syndrome and prenatal maternal smoking: Rising attributed risk in the back to sleep era. BMC Med 3 (2005) 4
7. Benowitz N.L. Cotinine as a biomarker of environmental tobacco smoke exposure. Epidemiol Rev 18 (1996) 188-204
8. Dempsey D., Jacob III P., and Benowitz N.L. Accelerated metabolism of nicotine and cotinine in pregnant smokers. J Pharmacol Exp Ther 301 (2002) 594-598
9. George L., Granath F., Johansson A.L., and Cnattingius S. Self-reported nicotine exposure and plasma levels of cotinine in early and late pregnancy. Acta Obstet Gynecol Scand 85 (2006) 1331-1337
10. Bardy A.H., Seppala T., Lillsunde P., Kataja J.M., Koskela P., Pikkarainen J., et al. Objectively measured tobacco exposure during pregnancy-neonatal effects and relation to maternal smoking. Br J Obstet Gynaecol 100 (1993) 721-726
11. Köhler E., Bretschneider D., Rabsilber A., Weise W., and Jorch G. Assessment of prenatal smoke exposure by determining nicotine and its metabolites in maternal and neonatal urine. Hum Exp Toxicol 20 (2001) 1-7
12. Cnattingius S. The epidemiology of smoking during pregnancy: Smoking prevalence, maternal characteristics, and pregnancy outcomes. Nicotine Tob Res 6 suppl 2 (2004) S125-S140
13. Witschi H., Joad J.P., and Pinkerton K.E. The toxicology of environmental tobacco smoke. Annu Rev Pharmacol Toxicol 37 (1997) 29-52
14. Parrott A.C. Nicotine psychobiology: How chronic-dose prospective studies can illuminate some of the theoretical issues from acute-dose research. Psychopharmacology (Berl) 184 (2006) 567-576
15. Gilbert D., McClernon J., Rabinovich N., Sugai C., Plath L., Asgaard G., et al. Effects of quitting smoking on EEG activation and attention last for more than 31 days and are more severe with stress, dependence, DRD2 A1 allele, and depressive traits. Nicotine Tob Res 6 (2004) 249-267
16. Breslau N., Kilbey M., and Andreski P. Nicotine dependence, major depression, and anxiety in young adults. Arch Gen Psychiatry 48 (1991) 1069-1074
17. Pritchard W.S., Robinson J.H., and Guy T.D. Enhancement of continuous performance task reaction-time by smoking in nondeprived smokers. Psychopharmacology (Berl) 108 (1992) 437-442
18. Kailasanath V, Fu S. The HOPES brain tutorial. The Huntington's Outreach Program for Education, at Stanford 2003. Available from: www.stanford.edu/group/hopes/basics/braintut/ab0.html [Accessed August 8, 2008].
19. Kuhn C., and Mailman R. Developmental neurotoxicology. In: Abou-Donia M. (Ed). Neurotoxicology (1992), CRC Press, Ann Arbor 293-318
20. Atluri P., Fleck M.W., Shen Q., Mah S.J., Stadfelt D., Barnes W., et al. Functional nicotinic acetylcholine receptor expression in stem and progenitor cells of the early embryonic mouse cerebral cortex. Dev Biol 240 (2001) 143-156
21. Eriksson P., Ankarberg E., and Fredriksson A. Exposure to nicotine during a defined period in neonatal life induces permanent changes in brain nicotinic receptors and in behaviour of adult mice. Brain Res 853 (2000) 41-48
22. Roy T.S., Andrews J.E., Seidler F.J., and Slotkin T.A. Nicotine evokes cell death in embryonic rat brain during neurulation. J Pharmacol Exp Ther 287 (1998) 1136-1144
23. Navarro H.A., Seidler F.J., Schwartz R.D., Baker F.E., Dobbins S.S., and Slotkin T.A. Prenatal exposure to nicotine impairs nervous-system development at a dose which does not affect viability or growth. Brain Res Bull 23 (1989) 187-192
24. Navarro H.A., Seidler F.J., Eylers J.P., Baker F.E., Dobbins S.S., Lappi S.E., et al. Effects of prenatal nicotine exposure on development of central and peripheral cholinergic neurotransmitter systems. Evidence for cholinergic trophic influences in developing brain. J Pharmacol Exp Ther 251 (1989) 894-900
25. Pugh P.C., and Margiotta J.F. Nicotinic acetylcholine receptor agonists promote survival and reduce apoptosis of chick ciliary ganglion neurons. Mol Cell Neurosci 15 (2000) 113-122
26. Kolb B. Brain-development, plasticity, and behavior. Am Psychol 44 (1989) 1203-1212
27. Yanai J. Neurobehavioral teratology (1984), Elsevier, Amsterdam
28. Roy T.S., and Sabherwal U. Effects of gestational nicotine exposure on hippocampal morphology. Neurotoxicol Teratol 20 (1998) 465-473
29. Navarro H.A., Mills E., Seidler F.J., Baker F.E., Lappi S.E., Tayyeb M.I., et al. Prenatal nicotine exposure impairs beta-adrenergic function: Persistent chronotropic subsensitivity despite recovery from deficits in receptor binding. Brain Res Bull 25 (1990) 233-237
30. Slotkin T.A., Lappi S.E., McCook E.C., Lorber B.A., and Seidler F.J. Loss of neonatal hypoxia tolerance after prenatal nicotine exposure: Implications for sudden infant death syndrome. Brain Res Bull 38 (1995) 69-75
31. Hafström O., Milerad J., Sandberg K.L., and Sundell H.W. Cardiorespiratory effects of nicotine exposure during development. Respir Physiol Neurobiol 149 (2005) 325-341
32. Slotkin T.A., Saleh J.L., McCook E.C., and Seidler F.J. Impaired cardiac function during postnatal hypoxia in rats exposed to nicotine prenatally: Implications for perinatal morbidity and mortality, and for sudden infant death syndrome. Teratology 55 (1997) 177-184
33. Seidler F.J., Levin E.D., Lappi S.E., and Slotkin T.A. Fetal nicotine exposure ablates the ability of postnatal nicotine challenge to release norepinephrine from rat-brain regions. Dev Brain Res 69 (1992) 288-291
34. Oncken C.A., Henry K.M., Campbell W.A., Kuhn C.M., Slotkin T.A., and Kranzler H.R. Effect of maternal smoking on fetal catecholamine concentrations at birth. Pediatr Res 53 (2003) 119-124
35. Paterson D.S., Trachtenberg F.L., Thompson E.G., Belliveau R.A., Beggs A.H., Darnall R., et al. Multiple serotonergic brainstem abnormalities in sudden infant death syndrome. JAMA 296 (2006) 2124-2132
36. Blair P.S., Sidebotham P., Berry P.J., Evans M., and Fleming P.J. Major epidemiological changes in sudden infant death syndrome: A 20-year population-based study in the UK. Lancet 367 (2006) 314-319
37. Xu Z., Seidler F.J., Ali S.F., Slikker Jr. W., and Slotkin T.A. Fetal and adolescent nicotine administration: Effects on CNS serotonergic systems. Brain Res 914 (2001) 166-178
38. Sugarman R. Structure and function of the neurologic system. In: McCance K., and Huether S. (Eds). Pathophysiology: The biologic basis for disease in adults and children. 5th ed (2006), Mosby, St. Louis, MO 441-446
39. Kinney H.C., Filiano J.J., and White W.F. Medullary serotonergic network deficiency in the sudden infant death syndrome: Review of a 15-year study of a single dataset. J Neuropathol Exp Neurol 60 (2001) 228-247
40. Becker K., El-Faddagh M., Schmidt M.H., Esser G., and Laucht M. Interaction of dopamine transporter genotype with prenatal smoke exposure on ADHD symptoms. J Pediatr 152 (2008) 263-269
41. Stein D.J., Fan J., Fossella J., and Russell V.A. Inattention and hyperactivity-impulsivity: Psychobiological and evolutionary underpinnings of ADHD. CNS Spectr 12 (2007) 190-197
42. Trauth J.A., Seidler F.J., Ali S.F., and Slotkin T.A. Adolescent nicotine exposure produces immediate and long-term changes in CNS noradrenergic and dopaminergic function. Brain Res 892 (2001) 269-280
43. Panigrahy A., Filiano J., Sleeper L.A., Mandell F., Valdes-Dapena M., Krous H.F., et al. Decreased serotonergic receptor binding in rhombic lip-derived regions of the medulla oblongata in the sudden infant death syndrome. J Neuropathol Exp Neurol 59 (2000) 377-384
44. Slikker Jr. W., Xu Z.A., Levin E.D., and Slotkin T.A. Mode of action: Disruption of brain cell replication, second messenger, and neurotransmitter systems during development leading to cognitive dysfunction-Developmental neurotoxicity of nicotine. Crit Rev Toxicol 35 (2005) 703-711
45. Slotkin T.A., Pinkerton K.E., Tate C.A., and Seidler F.J. Alterations of serotonin synaptic proteins in brain regions of neonatal Rhesus monkeys exposed to perinatal environmental tobacco smoke. Brain Res 1111 (2006) 30-35
46. Biederman J. Attention-deficit/hyperactivity disorder: A selective overview. Biol Psychiatry 57 (2005) 1215-1220
47. Thomas J.D., Garrison M.E., Slawecki C.J., Ehlers C.L., and Riley E.P. Nicotine exposure during the neonatal brain growth spurt produces hyperactivity in preweanling rats. Neurotoxicol Teratol 22 (2000) 695-701
48. Conners C.K., Levin E.D., Sparrow E., Hinton S.C., Erhardt D., Meck W.H., et al. Nicotine and attention in adult attention deficit hyperactivity disorder (ADHD). Psychopharmacol Bull 32 (1996) 67-73
49. Levin E.D., Conners C.K., Sparrow E., Hinton S.C., Erhardt D., Meck W.H., et al. Nicotine effects on adults with attention-deficit hyperactivity disorder. Psychopharmacology (Berl) 123 (1996) 55-63
50. Jacobsen L.K., Krystal J.H., Mencl W.E., Westerveld M., Frost S.J., and Pugh K.R. Effects of smoking and smoking abstinence on cognition in adolescent tobacco smokers. Biol Psychiatry 57 (2005) 56-66
51. Spring B., Cook J.W., Appelhans B., Maloney A., Richmond M., Vaughn J., et al. Nicotine effects on affective response in depression-prone smokers. Psychopharmacology (Berl) 196 (2008) 461-471
52. Breslau N. Psychiatric comorbidity of smoking and nicotine dependence. Behav Genet 25 (1995) 95-101
53. Jacobsen L.K., Slotkin T.A., Westerveld M., Mencl W.E., and Pugh K.R. Visuospatial memory deficits emerging during nicotine withdrawal in adolescents with prenatal exposure to active maternal smoking. Neuropsychopharmacology 31 (2006) 1550-1561
54. Glassman A.H. Cigarette smoking: Implications for psychiatric illness. Am J Psychiatry 150 (1993) 546-553
55. Slotkin T.A., Tate C.A., Cousins M.M., and Seidler F.J. Prenatal nicotine exposure alters the responses to subsequent nicotine administration and withdrawal in adolescence: Serotonin receptors and cell signaling. Neuropsychopharmacology 31 (2006) 2462-2475
56. Levin E.D., Lawrence S.S., Petro A., Horton K., Rezvani A.H., Seidler F.J., et al. Adolescent vs adult-onset nicotine self-administration in male rats: Duration of effect and differential nicotinic receptor correlates. Neurotoxicol Teratol 29 (2007) 458-465
57. Levin E.D., Rezvani A.H., Montoya D., Rose J.E., and Swartzwelder H.S. Adolescent-onset nicotine self-administration modeled in female rats. Psychopharmacology (Berl) 169 (2003) 141-149
58. Levin E.D., Lawrence S., Petro A., Horton K., Seidler F.J., and Slotkin T.A. Increased nicotine self-administration following prenatal exposure in female rats. Pharmacol Biochem Behav 85 (2006) 669-674
59. Abreu-Villaca Y., Seidler F.J., Tate C.A., Cousins M.M., and Slotkin T.A. Prenatal nicotine exposure alters the response to nicotine administration in adolescence: Effects on cholinergic systems during exposure and withdrawal. Neuropsychopharmacology 29 (2004) 879-890
60. Niaura R., Bock B., Lloyd E.E., Brown R., Lipsitt L.P., and Buka S. Maternal transmission of nicotine dependence: Psychiatric, neurocognitive and prenatal factors. Am J Addict 10 (2001) 16-29
61. Metherate R. Nicotinic acetylcholine receptors in sensory cortex. Learn Mem 11 (2004) 50-59
62. Liang K., Poytress B.S., Chen Y.L., Leslie F.M., Weinberger N.M., and Metherate R. Neonatal nicotine exposure impairs nicotinic enhancement of central auditory processing and auditory learning in adult rats. Eur J Neurosci 24 (2006) 857-866
63. Huang L.Z., Abbott L.C., and Winzer-Serhan U.H. Effects of chronic neonatal nicotine exposure on nicotinic acetylcholine receptor binding, cell death and morphology in hippocampus and cerebellum. Neuroscience 146 (2007) 1854-1868
64. Abdel-Rahman A., Dechkovskaia A.M., Sutton J.M., Chen W.C., Guan X., Khan W.A., et al. Maternal exposure of rats to nicotine via infusion during gestation produces neurobehavioral deficits and elevated expression of glial fibrillary acidic protein in the cerebellum and CA1 subfield in the offspring at puberty. Toxicology 209 (2005) 245-261
65. Jacobsen L.K., Slotkin T.A., Mencl W.E., Frost S.J., and Pugh K.R. Gender-specific effects of prenatal and adolescent exposure to tobacco smoke on auditory and visual attention. Neuropsychopharmacology 32 (2007) 2453-2464
66. Eppolito A.K., and Smith R.F. Long-term behavioral and developmental consequences of pre- and perinatal nicotine. Pharmacol Biochem Behav 85 (2006) 835-841
67. D'Onofrio B.M., Van Hulle C.A., Waldman I.D., Rodgers J.L., Harden K.P., Rathouz P.J., et al. Smoking during pregnancy and offspring externalizing problems: An exploration of genetic and environmental confounds. Dev Psychopathol 20 (2008) 139-164
68. Rigotti N.A., Park E.R., Chang Y., and Regan S. Smoking cessation medication use among pregnant and postpartum smokers. Obstet Gynecol 111 (2008) 348-355
69. GlaxoSmithKline. The bupropion pregnancy registry (2008), Kendle International, Wilmington, NC
70. Coleman T. Recommendations for the use of pharmacological smoking cessation strategies in pregnant women. CNS Drugs 21 (2007) 983-993
71. Pollak K.I., Oncken C.A., Lipkus I.M., Lyna P., Swamy G.K., Pletsch P.K., et al. Nicotine replacement and behavioral therapy for smoking cessation in pregnancy. Am J Prev Med 33 (2007) 297-305
72. Oncken C., Dornelas E., Greene J., Sankey H., Glasmann A., Feinn R., et al. Nicotine gum for pregnant smokers: A randomized controlled trial. Obstet Gynecol 112 (2008) 859-867
73. Gaither K.H., Huber L.R., Thompson M.E., and Huet-Hudson Y.M. Does the use of nicotine replacement therapy during pregnancy affect pregnancy outcomes?. Matern Child Health J 13 (2008) 497-504
74. Slotkin T.A. If nicotine is a developmental neurotoxicant in animal studies, dare we recommend nicotine replacement therapy in pregnant women and adolescents?. Neurotoxicol Teratol 30 (2008) 1-19
75. Sarasin A., Schlumpf M., Muller M., Fleischmann L., Lauber M.E., and Lichtensteiger W. Adrenal-mediated rather than direct effects of nicotine as a basis of altered sex steroid synthesis in fetal and neonatal rat. Reprod Toxicol 17 (2003) 153-162
76. Briggs G.G. Cigarette smoking cessation. OBGyn News 43 (2008) 9
77. US Department of Health and Human Services. Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. The health consequences of smoking: A report of the Surgeon General (2004), US Department of Health and Human Services, Washington, DC
78. Albrecht S.A., Caruthers D., Patrick T., Reynolds M., Salamie D., Higgins L.W., et al. A randomized controlled trial of a smoking cessation intervention for pregnant adolescents. Nurs Res 55 (2006) 402-410
79. Luck W., and Nau H. Exposure of the fetus, neonate, and nursed infant to nicotine and cotinine from maternal smoking. N Engl J Med 311 (1984) 672
80. Andersen A.N., Lund-Andersen C., Larsen J.F., Christensen N.J., Legros J.J., Louis F., et al. Suppressed prolactin but normal neurophysin levels in cigarette smoking breast-feeding women. Clin Endocrinol (Oxf) 17 (1982) 363-368
81. Amir L.H., and Donath S.M. Does maternal smoking have a negative physiological effect on breastfeeding? The epidemiological evidence. Breastfeed Rev 11 (2003) 19-29